Home / Diabetes In Control (page 276)

Diabetes In Control

Nike+ Running

Nike-running-image1

Nike Inc. iOS/Android Free   Although the Nike+ Running App may seem out of reach for some of our patients, the app is designed for all levels of activity. Nike has also been very supportive of their running fans and has kept the app up-to-date. The app has a lot of …

Read More »

ADA 2014 – GLP-1 Update

For this month’s special feature we have a selection of the GLP-1 abstracts and releases from the recent American Diabetes Association’s 74th Scientific Sessions in San Francisco. New one-year data of IDegLira shows glucose-lowering effect was maintained for people with type 2 diabetes New Phase 3a findings show IDegLira, the …

Read More »

Role of the Kidney, Part 4

DCMS193HS

  In this week’s Homerun Slides series, we review the Etiology of Type 2 Diabetes including Insulin Resistance and Beta-Cell Dysfunction, and we take also take a look at the San Antonio Metabolism and VAGES Studies….

Read More »

Joslin’s Diabetes Deskbook, Updated 2nd Ed., Excerpt #51: Pharmacotherapy of Type 2 Diabetes, Part 10

Joslin_Diabetes_Deskbook

Richard S. Beaser, MD Medications that Increase Insulin Secretion: SULFONYLUREAS CLASS SUMMARY: Action: Insulin secretagogues. Initial effects are to increase insulin secretory capacity. With establishment of long-term glucose control, this increase may not persist and other extrapancreatic effects, either direct or indirect, may also occur. Required for efficacy: Some remaining …

Read More »

Letter from the Editor #733

This week there is a lot of press on the use of insulin right after metformin and the increased risk of death in patients on this combination. Upon reading the entire article you see, however, that it is a retrospective review and unfortunately there is little if any data on …

Read More »